Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline

Synapse

Volumn 25, Issue 2, 1997, Pages 137-146

  Seeman, Philip ^a   Guan, Hong Chang ^a   Nobrega, José ^b   Jiwa, Dilshad ^b   Markstein, Rudolph ^c   Balk, Ja Hyun ^d   Picetti, Roberto ^d   Borrelli, Emiliana ^d   Van Tol, Hubert H M ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Preclinical Research   (Switzerland)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

D4 dopamine receptor; dopamine D2 knockout; dopamine D2 like receptor; Huntington's disease; Sandoz GLC 756 dopamine agonist; schizophrenia

Indexed keywords

1,2,3,4,4A,5,10,10A OCTAHYDRO 6 HYDROXY 1 METHYL 3 [(2 PYRIDYLTHIO)METHYL]BENZO[G]QUINOLINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BUTACLAMOL; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 5 RECEPTOR; GUANINE NUCLEOTIDE; GUANYLYLIMIDODIPHOSPHATE; NEUROLEPTIC AGENT; QUINOLINE DERIVATIVE; RACLOPRIDE; RADIOLIGAND; SULPIRIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING SITE; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; LIGAND BINDING; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BINDING SITES; CORPUS STRIATUM; DOPAMINE AGENTS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; QUINOLINES; RATS; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 0030950434     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199702)25:2<137::AID-SYN4>3.0.CO;2-D     Document Type: Article

References (29)

1. Andreasen, N.C., Rezai, K., Alliger, R., Swayze, V.W. II, Flaum, M., Kirchner, P., Cohen, G., and O'Leary, D.S. (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch. Gen. Psychiatry, 49:943-958.
2. Balk, J.-H., Picetti, R., Salardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M., and Borelli, E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377:424-428.
3. 50) of an enzymatic reaction. Biochem. Pharmacol., 22:3099-3108.
4. 1A dopamine receptors. Proc. Natl. Acad. Sci. USA, 91:12564-12568.
5. 11C]raclopride. Arch. Gen. Psychiatry, 47: 213-219.
6. Joyce, J.N., Shane, A., Lexow, N., Winokur, A., Casanova, M.F., and Kleinman, J.E. (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology, 8:315-336.
7. 3H]-NGD-94-1. Schizoph. Res., 18:173.
8. Lee, T., and Seeman, P., (1980) Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am. J. Psychiatry, 137:191-197.
9. 2 receptors. J. Neural. Transm., 103:17-30.
10. McGrath, J.J., Pemberton, M.R., Welham, J.L., and Murray, R.M. (1994) Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A Southern Hemisphere study. Schizophr. Res., 14:1-8.
11. McGue, M., and Gottesman, I.I. (1991) The genetic epidemiology of schizophrenia and the design of linkage studies. Eur. Arch. Psychiatry Clin. Neurosci., 240:174-181.
12. Murray, A.M., Hyde, T.M., Knable, M.B., Herman, M.M., Bigelow, L.B., Carter, J.M., Weinberger, D.R., and Kleinman, J.E. (1995) Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci., 15:2186-2191.
13. 11C]N-methylspiperone. Psychiatry Res. Neuroimaging, 61:67-84.
14. 4 receptors in drug-treated schizophrenia. Eur. J. Pharmacol., 281:5-6.
15. 4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective. Eur. J. Pharmacol., 233:173-174.
16. 4 receptor varies with the affinity of the competing radioligand. Eur. J. Pharmacol., 291:59-66.
17. Seeman, P., Chau-Wong, M., Tedesco, J., and Wong, K. (1975) Brain receptors for antipsychotic drugs and dopamine: Direct binding assays Proc. Natl. Acad. Sci. USA, 72:4376-4380.
18. Seeman, P., Lee, T., Chau-Wong, M., and Wong, K. (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261: 717-719.
19. 2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases. Neuropsychopharmacology 1:5-15.
20. Seeman, P., Niznik, H.B., Guan, H.-C., Booth, G., and Ulpian, C. (1989) Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc. Natl. Acad. Sci. USA, 86:10156-10160.
21. 2 receptor reveals different densities for dopamine antagonist ligands. Implications for human brain positron emission tomography. Eur. J. Pharmacol., 227:139-146.
22. Seeman, P., Guan, H.-C., Van Tol, H.H.M. (1993) Dopamine D4 receptors elevated in schizophrenia. Nature, 365:441-445.
23. 125I]epidepride. Eur. J. Pharmacol., 286:3-5.
24. 3H]raclopride binding in postmorten caudate nucleus of subjects with schizophrenia or major depression. Brain Res., 681:109-116.
25. Torrey, E.F. (1992) Are we overestimating the genetic contribution to schizophrenia? Schizophr. Bull., 18:159-170.
26. 11C-N-methylspiperone. Psychiatry Res., 49:219-237.
27. 4 receptor with high affinity for the antipsychotic clozapine. Nature, 350:610-614.
28. Wreggett, K.A., and Wells, J.W. (1995) Cooperatively manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem., 270:22488-22499.
29. Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G.F., Graybiel, A.M., and Tonegawa, S. (1994) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral response. Cell, 79:729-742.